Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

7.180 +0.590 (+8.95%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Hldgs Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
2 Bruised Growth Stocks to Buy While They're Cheap
Both are on the verge of fast growth, and they haven't had any major setbacks yet. 
Via The Motley Fool
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023. 
Via InvestorPlace
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock
Ginkgo Bioworks has tumbled this week, but Cathie Wood is among the key buyers of DNA stock, picking up shares yesterday. 
Via InvestorPlace
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Ginkgo Bioworks Holdings's Earnings: A Preview
Via Benzinga
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
From Cronos Group Inc.
Via GlobeNewswire
To The Moon: Intuitive Machines Blasts 10x in a Week...But Why?
The modern version of the Cold War Space Race has implications for scientific discovery and satellite communications. Intuitive Machines is in the thick of it. 
Via MarketBeat
This Biotech Is Already Using AI, but Is the Growth Stock a Buy?
Few biotechs can claim to be using AI in as central of a role as Ginkgo Bioworks. 
Via The Motley Fool
Is It Too Early to Invest in Ginkgo Bioworks?
Ginkgo is on track to easily beat its guidance for 2022. But what about its bottom line? 
Via The Motley Fool
Investigation Announced for Investors Who Lost Money with NYSE: DNA Shares over Possible Violations of Securities Laws by Ginkgo Bioworks Holdings, Inc.
San Diego, CA -- (SBWIRE) -- 02/01/2023 -- An investigation was announced for investors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares over potential securities laws violations by Ginkgo Bioworks... 
Via SBWire
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
3 Penny Stocks That Could Rise 500% in 2023
Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 35 companies reached new 52-week lows. 
Via Benzinga
What You Missed On Wall Street On Friday
In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold. 
Via Talk Markets
Three Pharma Stocks to Sell Before They Die
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January. 
Via InvestorPlace
Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
The company's strategy will take time to implement, but it'll make investors a lot richer if it works. 
Via The Motley Fool
Analyzing Ginkgo Bioworks Holdings's Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 7.31% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 14.71% of all... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 14.12% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 15.87% of all... 
Via Benzinga
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Ginkgo Bioworks Stock Is Sliding Wednesday Morning
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower by 8.63% to $2.44 Wednesday morning. The company during Tuesday's after-hours session announced a public offering of Class A common... 
Via Benzinga
Carnival, Ginkgo Bioworks And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Ginkgo Bioworks Stock Is Down After Hours: What's Happening?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering. 
Via Benzinga
What's Going On With Ginkgo Bioworks Stock After Hours?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company  
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.